In conclusion, our study demonstrates that a CRC liver metastasis-specific cholesterol metabolic pathway that involves the activation of SREBP2-dependent cholesterol biosynthesis is established for colonization of metastatic CRC cells in the liver. This evidence concerns the gene SREBF2 and colorectal carcinoma.